ArticleDiscover oncology2026

Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab.

Erdem Kolemen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.